NCT05335265

A Comparison of Classic and Virtual Inhaler Training Methods in COPD Patients

Completed NA Last updated 28 April 2022

What this trial tests

NA trial testing Treatment training in COPD in 102 participants. Completed in 31 December 2021.

Timeline

1 October 2021

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Ayse Baha
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	102
Start date	1 October 2021
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	9 locations across Turkey (Türkiye)

Drugs / interventions tested

• Treatment training

Conditions studied

• COPD — all drugs for COPD →
• Inhaler Training — all drugs for Inhaler Training →
• Face-to-face Training — all drugs for Face-to-face Training →
• Video-mediated Virtual Training — all drugs for Video-mediated Virtual Training →

Sponsor

Ayse Baha

Who can join

Adults 40 to 65, any sex, with COPD or Inhaler Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

According to the World Health Organization data, the third most common cause of death in the world, is COPD , a disease that progresses with exacerbations (1). Exacerbations are the most important cause of morbidity and mortality in COPD (2). It is thought that most exacerbations occur (3,4) because highly effective inhaler treatments are unavailable to prevent and treat respiratory symptoms (5,6). However, using inhaler devices correctly can be difficult (jama7,8). Guidelines recommend evaluating and teaching inhaler use technique (5,6). Unfortunately, these are often not implemented, especially in a hospital setting (9,10). Worldwide, 25 billion dollars are spent annually on inhaler drugs, 5-7 billion dollars of which is estimated to be wasted because of incorrect technique. Beyond this financial cost, incorrect inhaler technique is associated with worse symptom control, lower quality of life and increased acute care costs, (11,12,13). Although these shortcomings are known, appropriate educational interventions are unfortunately not been available.

Additionally , patient's access to health services (especially face-to-face communication with recommended health providers) has been largely prevented due to the restrictions/requirements implemented against the pandemic in 2020,such as social isolation, staying away from public environments, and ensuring good personal and social hygiene.

Considering that inhaler training is done face-to-face by doctors or allied health personnel today, many patients did not receive inhaler drug use training. One of the most realistic solutions that we encountered with this pandemic is telemedicine. The use of internet-mediated training, which is a part of telemedicine, has come to the foreground. In a recently published study on chronic airway diseases (asthma and COPD), it was revealed that video-mediated inhaler training is as successful as classical face-to-face training (14).Our aim is to investigate whether video-mediated virtual inhaler training is successful in patients with COPD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.